Universita della Svizzera Italiana Researcher Yields New Data on Breast Cancer (Albumin-To-Alkaline Phosphatase Ratio as a New Early Predictive Marker of Axillary Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Pilot...).

A recent study conducted by researchers at Universita della Svizzera Italiana in Lugano, Switzerland, focused on the Albumin-to-Alkaline Phosphatase ratio (AAPR) as a potential predictive marker for axillary response in breast cancer patients undergoing neoadjuvant chemotherapy. The study found that a low AAPR may correlate with a poor response to chemotherapy in primary tumors, and that the AAPR could potentially predict axillary response in initially nodal-positive breast cancer patients. The researchers concluded that further investigation in larger prospective trials is needed to validate these findings. For more information, readers can refer to the original article published in Medicina. [Extracted from the article]